Prolonged Aldose Reductase Inhibition in Chronic Peripheral Diabetic Neuropathy: Effects on Microangiopathy

Diabetic Medicine

Volumn 7, Issue 1, 1990, Pages 63-68

  Jennings, P E ^a   Nightingale, S ^a   Guen, C Le ^a   Lawson, N ^a   Williamson, J R ^b   Hoffman, P ^b   Barnett, A H ^a  

^a BIRMINGHAM HEARTLANDS HOSPITAL   (United Kingdom)

^b WASHINGTON UNIVERSITY   (United States)

Author keywords

Aldose reductase inhibition; Basement membrane; Chronic neuropathy; Microalbuminuria; Platelets

Indexed keywords

ALDEHYDE REDUCTASE; SORBINIL;

ADULT; ARTICLE; BASEMENT MEMBRANE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; DIABETIC NEUROPATHY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG HYPERSENSITIVITY; ENZYME INHIBITION; FEMALE; HUMAN; MALE; MICROALBUMINURIA; MICROANGIOPATHY; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; RASH; THROMBOCYTE AGGREGATION;

ALDEHYDE REDUCTASE; BASEMENT MEMBRANE; BLOOD PRESSURE; CAPILLARIES; CLINICAL TRIALS; DIABETIC ANGIOPATHIES; DIABETIC NEUROPATHIES; DOUBLE-BLIND METHOD; FEMALE; FOLLOW-UP STUDIES; HUMAN; IMIDAZOLES; MALE; MIDDLE AGE; MUSCLES; NEURAL CONDUCTION; PERCEPTION; RANDOM ALLOCATION; REGIONAL BLOOD FLOW; SUGAR ALCOHOL DEHYDROGENASES; SUPPORT, NON-U.S. GOV'T;

EID: 0025019609     PISSN: 07423071     EISSN: 14645491     Source Type: Journal    
DOI: 10.1111/j.1464-5491.1990.tb01310.x     Document Type: Article

References (41)

1. Diabetic neuropathy
2. The sorbitol pathway and the complications of diabetes
3. Diabetic neuropathy. New concepts of its aetiology
4. The biochemistry of the complications of diabetes mellitus
5. The effect of aldose reductase inhibition on motor nerve conduction velocity in diabetic rats
6. Reversal by treatment with an aldose reductase inhibitor, of impaired axonal transport and motor nerve conduction velocity in experimental diabetes mellitus
7. The effects of Sorbinil on peripheral nerve conduction velocity, polyol concentrations and morphology in the streptozotocin‐diabetic rat
8. Aldose reductase inhibition improves nerve conduction velocity in diabetic patients
9. Treatment of severely painful diabetic neuropathy with an aldose reductase inhibitor: relief of pain and improved somatic and autonomic nerve function
10. A controlled trial of Sorbinil, an aldose reductase inhibitor, in chronic painful diabetic neuropathy
11. Clinical and neurophysiological studies with the aldose reductase inhibitor, Sorbinil, in symptomatic diabetic neuropathy
12. Six‐month treatment with Sorbinil in asymptomatic diabetic neuropathy
13. Aldose reductase inhibition in diabetic neuropathy: Clinical and neurophysiological studies of one year's treatment with Sorbinil
14. Capillary number and percentage closed in human diabetic sural nerve
15. Reassessment of vascular factors in relation to intravascular coagulation
16. Nerve biopsy and conduction studies in diabetic neuropathy
17. Muscle capillary membrane thickening in diabetic patients with chronic peripheral neuropathy, retinopathy and microalbuminuria (Abstract)
18. Sural oxygen tension in diabetes
19. Abnormal platelet aggregation in chronic symptomatic diabetic peripheral neuropathy
20. Platelet abnormalities in diabetic peripheral neuropathy
21. Microalbuminuria in diabetic subjects with chronic peripheral neuropathy
22. Microalbuminuria as a predictor of clinical neuropathy in insulin dependent diabetes mellitus
23. Microalbuminuria and diabetic retinopathy
24. Aldose reductase activity and basement membrane thickening
25. Glomerular polyol accumulation in diabetes and its prevention by oral Sorbinil
26. Standardisation methods of determining vibratory perception thresholds for diagnosis and screening in neurological investigations
27. Quantitative determination of glycosylated haemoglobin A, by agar gel electrophoresis
28. Aggregation of blood platelets by adenosine diphosphate and its reversal
29. Predicting microalbuminuria without measuring urinary flow rate (Abstract)
30. Muscle capillary basement membrane changes related to ageing and to diabetes mellitus
31. Permeability changes in blood‐retinal barrier of galactosemic rats are prevented by aldose reductase inhibitors
32. Effect of Sorbinil on blood‐retinal barrier in early diabetic retinopathy
33. Diabetes induced increases in vascular permeability and changes in granulation tissue levels of Sorbinil, myoinositol, chiro‐inositol and scyllo‐inositol are prevented by Sorbinil
34. Galactose ingestion increases vascular permeability and collagen solubility in normal male rats
35. The pharmacology of aldose reductase inhibitors
36. Retinal capillaries: basement membrane thickening by galactosemia prevented with aldose reductase inhibitors
37. Relationship of muscle capillary basement membrane to renal structure and function in diabetes mellitus
38. Action of Sorbinil in diabetic peripheral nerve: relationship of polyol (sorbitol) pathway inhibition to a myo‐inositol‐mediated defect in sodium‐potassium ATPase activity
39. Na+‐K+‐ATPase pumping activity is not directly linked to myo‐inositol levels after Sorbinil treatment in lenses of diabetic rats
40. Sorbitol, phospho‐inositides and sodium‐potassium‐ATPase in the pathogenesis of diabetic complications
41. New approaches to the problem of diabetic microangiopathy